Home / Learn

Learn

ACCC education and advocacy support offers our multidisciplinary membership a variety of diverse and enriching resources that address the complex changes and challenges in delivering quality cancer care.

Our ever-growing ACCC community of nearly 30,000 practitioners and healthcare professionals have access to member-driven education programs delivered in a wide range of formats. These formats include live national and regional meetings, webinars, workshops, publications, white papers, case studies, surveys, environmental scans, and literature reviews, as well as onsite learning opportunities, peer-to-peer learning, focus groups, and more.

ACCC members are invited to get involved. Contact us at resources@accc-cancer.org to learn more.

ACCC offers education and resources to help multidisciplinary cancer care teams stay informed of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.

ACCC is dedicated to helping the oncology community advance new therapies, expand access to clinical trials, and to close the gap in cancer care delivery by offering the latest education and resources on real-world research, evidence, and clinical trials.

Cancer care services that address the full spectrum of a patient’s needs—physical, nutritional, emotional, psychosocial, spiritual, and financial—have been found to greatly improve survivor’s quality of life and outcomes.

Through the Financial Advocacy Network tools and resources, ACCC's goal is to empower providers to proactively integrate financial health into the oncology care continuum and help patients gain access to high-quality care for a better quality of life.

By supporting our members and the entire oncology specialty, we can prioritize equity, diversity, and inclusion in quality cancer care delivery, as well as within the oncology workforce.

ACCC is leading the way in transforming oncology practice management and operations resources that connect real-world challenges with real-world solutions.

Helping to bring personalized cancer care into focus, ACCC transforms complex science into clear and actionable education that brings clarity to patient care decisions.

ACCC offers a variety of webinars, continuing education opportunities, abstracts, presentations, the Oncology Issues journal, and more publications.

Webinars & E-Learning

The ACCCeLearning platform provides multidisciplinary education and resources that support the different needs of our members. With a variety of flexible online learning options that fit individual learning preferences, you have your choice of in-depth courses or shorter learning formats to gain quick knowledge.

Explore by Topic

Latest On-Demand Webinars

Optimizing Treatment with Molecular Tumor Boards

Learn from experts Derek B. Allison, MD, and Justine C. Pickarski, MS, LGC, about how they developed Markey Cancer Center’s statewide molecular tumor board as well as lessons learned and key takeaways.
Cultivating Care: Growing Sustainable Financial Advocacy Programs to Better Serve Patients

For people living with cancer, the financial challenges of treatment can create significant burdens across the continuum of care. In this webinar, Dr. Margaret Liang will explore some of the drivers and sources of financial toxicity for patients and shed light on the Association of Cancer Care Centers Financial Advocacy Services Guidelines, an evidence-based framework developed by experts and patient advocates to prevent, detect, and mitigate financial hardship during cancer care. Learn how the guidelines, which include an assessment tool that identifies program gaps and opportunities, offer cancer care centers a customizable pathway to expand their capacity to equitably serve patients with cancer.
Expanding Access to Cellular and Bispecific Therapies: Considerations and Recommendations

A live Question & Answer session for attendees interested in beginning their own program will also be offered.

View Complete Library of Virtual Education

Continuing Education Activities

ACCC’s mission is to promote the education and training of the multidisciplinary oncology care team, with the goal of improving the treatment and management of patients with cancer. Our portfolio includes education for all learners, regardless of the stage they are in their career.

Advances in Cancer Immunotherapy Series: A Focus on Toxicity Management

Advances in Cancer Immunotherapy Series: A Focus on Genitourinary Cancers

Tuesday, June 11 from 11 AM-3 PM EST

Join SITC and a panel of experts, via Zoom, for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers. FREE for healthcare professionals, students, patients and patient advocates.

Physician Education: 3.75 AMA PRA Category 1TM
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours
Register Now

Advances in Cancer Immunotherapy Series: A Focus on Lung Cancer

Advances in Cancer Immunotherapy Series: A Focus on Hematologic Malignancies

Advances in Cancer Immunotherapy Series: A Focus on Intratumoral Therapies Vaccines and Cytokines

Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in Metastatic Colorectal Cancer (mCRC)

In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps. At the end of this workshop, participants will be able to develop a personalized action plan for incorporating new insights and competencies into practice, learn to develop practical biomarker testing protocols for metastatic colorectal cancer, and how this information can support personalized treatment decisions for improved patient outcomes.

Credits Available: This activity is awarded 4.5 hours of AMA PRA Category 1 Credit(s)™ and nursing contact hours. For additional CE information, please visit tffevents.com/crc.

More Information

Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer

Included in this course are data from the PEACE-1 phase 3 trial exploring triple therapy, ongoing trials in metastatic castration-sensitive prostate cancer, and quality of life studies on systemic therapies.

This activity provides guidance on the optimal management of mCSPC to oncologists, urologists, oncology advanced practitioners and other members of the multidisciplinary cancer care team. The program addresses some of the challenges in optimal sequencing of care in mCSPC and provides an opportunity to discuss with leading oncology experts and colleagues how new research clinical updates can be translated into new patient care strategies.

Speakers:

Archana Ajmera, MSN, ANP-BC-AOCNP, Advanced Practice Provider Supervisor, Division of Hematology/Oncology, UCSD Moores Cancer Center
Pedro C. Barata, MD, MSC, Assistant Professor, Deming Department of Medicine Division of Hematology/Oncology, Genitourinary Cancers Tulane University, Tulane University
Erik Castle, MD, FACS, Professor of Urology, Tulane University
Lisa M. Holle, PHARMD, BCOP, FHOPA, FISOPP, Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, UConn School of Medicine

View Course

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management

This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

Session 1:  Learn what factors influence testing selection for patients with advanced NSCLC.
Session 2:  Gain clarity on biomarker testing methodology and recommendations.
Session 3:  Hear insights on advanced NSCLC treatment opportunities and optimizing patient care.

Credits Available: This activity offers up to 4.5 hours of CME/CMLE credit.
Enroll Today

Presentations and Abstracts

ACCC presents oral and poster presentations that represent the spectrum of cancer care at international conferences throughout the year.

[Abstract] Perceived Barriers to Optimal Care in Head and Neck Cancer: A Mixed-Methods Study Nov 14, 2024

Presented at Journal of the Advanced Practitioner in Oncology (JADPRO) Live 2024 in Grapevine, Texas.
Improving Care Coordination to Address Healthcare Inequities in Lung Cancer Nov 11, 2024
Presented at the IASCL 2024 World Conference on Lung Cancer.
[Abstract 6079 and Poster 394] Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study Jun 18, 2024

This is a visual representation of an online publication from the American Society of Clinical Oncology 2024 Annual Meeting, May 31 – June 4, 2024.

View All Presentations and Resources by Topic

Publications

ACCC members consistently give ACCC publications high marks for their timeliness and usefulness. Experts in the field of oncology contribute to ACCC's publications and provide a solution-based approach to educating oncology healthcare professionals about streamlining and improving cancer services, practice management trends and strategies; implementing new treatments and technology; and planning for regulatory and legislative change.

Oncology Issues

Oncology Issues is the official journal of the Association of Community Cancer Centers (ACCC). As one of the only non-clinical, programmatic journals covering cancer, Oncology Issues provides “how-to” articles for the entire multidisciplinary oncology care team, on a wide range of topics.

Implementing Smart Texting to Reduce Inpatient Admissions and Emergency Department Visits

2024 ACCC Innovator Award winner Mercy Health used predictive algorithms and smart texting to significantly reduce inpatient admissions and emergency department visits for patients with cancer. By proactively engaging high-risk patients through digital outreach, Mercy ensures timely symptom management and improves the overall quality of life for those undergoing chemotherapy, creating new benchmarks in patient-centered health care.
Read Full Article

Also In This Issue:

A Sustainable Model for Pancreatic Cyst Surveillance and Early Pancreatic Cancer Detection
Cooperman Barnabas Medical Center received a 2024 Innovator Award for its use of AI software integrated with the electronic health record to accurately identify and capture pancreatic abnormalities from radiology reports and conduct longitudinal surveillance of patients.
Creating a Community-Wide Safety Net With Centralized Tracking and Management of Incidental Lung Nodules
To ensure appropriate follow-up for patients with incidental lung nodules, 2024 Innovator Award winner UCHealth leveraged an AI solution to evaluate radiology interpretations, identify incidental lung nodules and their characteristics, and stratify and triage patients within their database based on risk level. Equipped to automatically send tailored communications to patients, track follow-up imaging and exams, and update the database for ongoing surveillance, this solution effectively created a safety net for all patients with incidental lung nodules.
An Innovative Program Addresses Housing Insecurity
Over the past 15 years, Montefiore Health System’s Housing at Risk Program has worked to bridge the gap between medical care and social services through its robust database, early identification system for high-risk patients, and comprehensive follow-up. By treating patients as whole individuals and addressing the root causes of their challenges, the team has redefined what it means to provide care.
Adverse Event Management for CDK Inhibitors in Hormone Receptor–Positive Breast Cancer
Three CDK4/6 inhibitors have recently been approved for use in patients with breast cancer to slow and stop the growth of cancer cells. Learn more about the common adverse effects and management strategies to promote adherence to these agents.
Bridging Oncology and Dermatology: Integrating Dermatologic Toxicity Management Into Routine Cancer Care
Although diagnosis and symptom severity may vary, most patients undergoing cancer therapy will experience a dermatologic adverse event at some point during treatment, often causing physical discomfort, emotional distress, financial burdens, and even interruptions in life-saving cancer therapy. Learn more about the positive impact of supportive oncodermatology services and how cancer centers have integrated these services into their continuum of care.
Addressing Social Drivers of Health: A Quality Improvement Approach to Developing Oncology-Specific Screening Tools
Social drivers of health can significantly influence a patient’s ability to receive a timely diagnosis, access specialized care, adhere to treatment plans, and obtain support for managing their condition. To address the inequalities stemming from these social drivers, ACCC developed an oncology-specific screening tool and resource library to better equip multidisciplinary cancer care teams with the skills needed to identify and address these barriers to care.
Bringing Cancer Research to the Community: Strategic Approaches to Representative Oncology Clinical Trial Design
In an effort to collaboratively and strategically reduce barriers to clinical trial participation, ACCC Community Oncology Research Institute hosted the Community Inclusive Clinical Trial Design Summit in the fall of 2024. Key actionable strategies that emerged from the discussion include the need to strengthen the clinical trial workforce, engage with communities outside of clinical trial interactions, and expand research access through decentralized clinical trials.
Treatment for Relapsed or Refractory Multiple Myeloma: Care Team Perspectives on a Bispecific Antibody
With the emergence of bispecific antibody therapies in multiple myeloma, community cancer centers are establishing clinical protocols to support patients receiving care locally. Hear from a multiple myeloma treatment team about their experience implementing a bispecific antibody therapy in the community setting.